Valink Therapeutics
Cambridge, Massachusetts, United States · Biotechnology, Health Care, Therapeutics
Valink Therapeutics focusses on synergistic and non-obvious target combinations to create novel multivalent bispecific antibody-drug conjugates (bsADCs) that transform the treatment of solid tumors and other indications.
Key facts
- Headquarters
- Cambridge, Massachusetts, United States
- Employees
- 26
- Industries
- Biotechnology, Health Care, Therapeutics
- Status
- Private
- Website
- valinktx.com
- Company page
Recent activity at Valink Therapeutics
Valink Therapeutics funding history
| Date | Round | Amount |
|---|---|---|
| Oct 2025 | Pre-Series A | $11.8M |
Leadership
- Arne Scheu, Founder
- Irsyad Khairil, Founder
Verified email and direct lines for Valink Therapeutics’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Valink Therapeutics in the news
Companies similar to Valink Therapeutics
- GenSight Biologics · Biotechnology, Health Care, Therapeutics
- Nuvig Therapeutics · Biotechnology, Health Care, Therapeutics
- Mosaic Therapeutics · Biotechnology, Health Care, Therapeutics
- Neogap Therapeutics · Biotechnology, Health Care, Therapeutics
- Navigator Medicines · Biotechnology, Health Care, Therapeutics
About Valink Therapeutics: questions and answers
What does Valink Therapeutics do?
Valink Therapeutics focusses on synergistic and non-obvious target combinations to create novel multivalent bispecific antibody-drug conjugates (bsADCs) that transform the treatment of solid tumors and other indications.
Where is Valink Therapeutics headquartered?
Valink Therapeutics is headquartered in Cambridge, Massachusetts, United States.
How many employees does Valink Therapeutics have?
Valink Therapeutics has about 26 employees.
Has Valink Therapeutics raised funding?
Yes. Fundz has recorded 1 funding event for Valink Therapeutics. The most recent, Pre-Series A of $11.8M, was in Oct 2025.
Who leads Valink Therapeutics?
Arne Scheu is a Founder at Valink Therapeutics.
What is the latest news on Valink Therapeutics?
On Dec 17, 2025, Valink Therapeutics and Nona Biosciences Establish Strategic Alliance to Enhance Biologics Discovery.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy